Reuters logo
BRIEF-Zynerba provides clinical update for lead development candidates - ZYN001 and ZYN002
October 17, 2016 / 11:16 AM / a year ago

BRIEF-Zynerba provides clinical update for lead development candidates - ZYN001 and ZYN002

Oct 17 (Reuters) - Zynerba Pharmaceuticals Inc :

* Zynerba Pharmaceuticals Inc - topline results for three phase 2 clinical trials for ZYN002 are on track for 1h17

* Zynerba - phase 1 clinical trial for zyn001 is expected to begin in 1h17

* Phase 2 clinical trials are now planned to begin during second half of 2017

* Zynerba - phase 2 clinical trials in patients with fragile X syndrome (FXS) are on track to begin before end of 2016. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below